Región Metropolitana de Santiago
Este organismo compró $35.329.096.472 en 11.633 órdenes de compra , sobre todo en Medicamentos y productos farmacéuticos / Medicamentos anti infecciosos / Medicamentos antivirales y le compró principalmente a Sur Medical SpA.
238 meses con data · color por monto (sqrt scale)
| Año | Ene | Feb | Mar | Abr | May | Jun | Jul | Ago | Sep | Oct | Nov | Dic | Total año |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
| $1367,1 M |
| 2025 | $2402,7 M |
| 2024 | $2107,2 M |
| 2023 | $2816,8 M |
| 2022 | $1338 M |
| 2021 | $1018,6 M |
| 2020 | $888,8 M |
| 2019 | $901,2 M |
| 2018 | $1471,2 M |
| 2017 | $786,1 M |
| 2016 | $14,2 mil M |
| 2015 | $919,8 M |
| 2014 | $428,8 M |
| 2013 | $340,8 M |
| 2012 | $359,5 M |
| 2011 | $701,4 M |
| 2010 | $913,7 M |
| 2009 | $590,7 M |
| 2008 | $571,8 M |
| 2007 | $1180,7 M |
| 2006 | $34,7 M |
238 períodos con data
Fuente: Agregaciones mensuales sobre OCs ingeridas
10 contrapartes
Fuente: Tabla top_contrapartes_comprador
| Código | Fecha | Proveedor | Estado | Monto |
|---|---|---|---|---|
| 2980-285-AG26 | 17-06-2026 | Novartis Chile S.A. | Aceptada | $3.997.817 |
| 2980-276-AG26 | 17-06-2026 | Novofarma Service S.A. | Aceptada | $7.140.143 |
| 2980-290-AG26 | 17-06-2026 | Johnson y Johnson de Chile S.A. | Aceptada | $1.667.476 |
| 2980-284-AG26 | 15-06-2026 | Bayer S.A. | Recepcion Conforme | $6.735.909 |
| 2980-274-AG26 | 15-06-2026 | Bayer S.A. | Recepcion Conforme | $6.735.909 |
| 2980-273-AG26 | 08-06-2026 | Obentis SpA | Recepcion Conforme | $5.934.982 |
| 2980-272-AG26 | 05-06-2026 | Clinical Market S.A. | Recepcion Conforme | $1.872.156 |
| 2980-265-AG26 | 04-06-2026 | Glaxosmithkline Chile Farmaceutica Limitada | Recepcion Conforme | $191.977 |
| 2980-263-AG26 | 04-06-2026 | Glaxosmithkline Chile Farmaceutica Limitada | Recepcion Conforme | $736.194 |
| 2980-271-AG26 | 04-06-2026 | Pfizer Chile S.A. | Recepcion Conforme | $3.519.235 |
| 2980-270-AG26 | 04-06-2026 | Bayer S.A. | Recepcion Conforme | $6.735.909 |
| 2980-266-AG26 | 04-06-2026 | Novofarma Service S.A. | Recepcion Conforme | $2.380.048 |
| 2980-264-AG26 | 04-06-2026 | Dr. Reddys Laboratories Chile SpA | Recepcion Conforme | $3.034.500 |
| 2980-268-AG26 | 04-06-2026 | Johnson y Johnson de Chile S.A. | Recepcion Conforme | $5.002.427 |
| 2980-267-AG26 | 03-06-2026 | Maria Elena Bustamante Mella | Recepcion Conforme | $1.110.032 |
| 2980-259-SE26 | 01-06-2026 | Fundacion Dr Jorge Perez Rifo | Recepcion Conforme | $5.176.543 |
| 2980-261-SE26 | 01-06-2026 | Fundacion Dr Jorge Perez Rifo | Recepcion Conforme | $18.318.997 |
| 2980-257-AG26 | 01-06-2026 | Johnson y Johnson de Chile S.A. | Recepcion Conforme | $5.002.427 |
| 2980-256-AG26 | 01-06-2026 | Novofarma Service S.A. | Recepcion Conforme | $1.313.660 |
| 2980-260-SE26 | 01-06-2026 | Fundacion Dr Jorge Perez Rifo | Recepcion Conforme | $1.057.490 |
| 2980-255-AG26 | 01-06-2026 | Alembic Pharmaceuticals SpA | Recepcion Conforme | $339.864 |
| 2980-262-SE26 | 01-06-2026 | Fundacion Dr Jorge Perez Rifo | Recepcion Conforme | $14.059.664 |
| 2980-254-AG26 | 22-05-2026 | Hm Service SpA | Aceptada | $379.148 |
| 2980-220-AG26 | 22-05-2026 | Comercializadora de Alimentos Especializados, Medicamentos y Dispositivos Medico | Aceptada | $999.600 |
| 2980-237-AG26 | 22-05-2026 | Pfizer Chile S.A. | Aceptada | $146.370 |
| 2980-238-AG26 | 22-05-2026 | Askeny Chile SpA | Aceptada | $1.635.421 |
| 2980-239-AG26 | 22-05-2026 | Merck Sharp & Dohme (I.a) Llc,agencia en Chile | Aceptada | $386.096 |
| 2980-241-AG26 | 22-05-2026 | Distribuidora Qualimed Limitada | Aceptada | $1.872.390 |
| 2980-246-AG26 | 22-05-2026 | Glaxosmithkline Chile Farmaceutica Limitada | Aceptada | $896.457 |
| 2980-219-AG26 | 22-05-2026 | Synthon Chile Limitada | Aceptada | $1.135.321 |
